subject area of
- A Prospective Randomized Study of Alpha-2b Interferon plus Hydroxyurea or Cytarabine for Patients with Early Chronic Phase Chronic Myelogenous Leukemia: The International Oncology Study Group CML1 Study Journal Articles
- A randomized study of alpha‐interferon plus ribavirin for 6 months or 12 months for the treatment of chronic hepatitis C in patients with bleeding disorders Journal Articles
- Antiviral treatment for chronic hepatitis C in patients with human immunodeficiency virus Journal Articles
- Application strategies of serum HBV DNA detection in HBV infection patients: A retrospective study of 5611 specimens. Journal Articles
- Bovine herpesvirus type 1 as a novel oncolytic virus Journal Articles
- Chromatin Dynamics of Gene Activation and Repression in Response to Interferon α (IFNα) Reveal New Roles for Phosphorylated and Unphosphorylated Forms of the Transcription Factor STAT2 Journal Articles
- Clinical trial: exposure to ribavirin predicts EVR and SVR in patients with HCV genotype 1 infection treated with peginterferon alfa‐2a plus ribavirin Journal Articles
- Combination 13-cis-retinoic acid and interferon alpha-2a in the therapy of solid tumors. Journal Articles
- Combination 13-cis-retinoic acid and interferon alpha-2a in the therapy of solid tumors. Journal Articles
- Cost-effectiveness of a Transplantation Strategy Compared to Melphalan and Prednisone in Younger Patients with Multiple Myeloma Journal Articles
- Direct-acting antiviral therapies for hepatitis C genotype 1 infection: a multiple treatment comparison meta-analysis Journal Articles
- Dose-Dependent Development of Depressive Symptoms During Adjuvant Interferon- Treatment of Patients With Malignant Melanoma Journal Articles
- Effect of conventional interferon‐α in patients with HBeAg‐positive chronic hepatitis B: a systematic review and meta‐analysis Journal Articles
- Effects of complete vagotomy and blockage of cell adhesion molecules on interferon-α induced behavioral changes in mice Journal Articles
- Efficacy and Safety of Pegylated Interferon Alfa-2a or Alfa-2b Plus Ribavirin for the Treatment of Chronic Hepatitis C in Children and Adolescents: A Systematic Review and Meta-analysis Journal Articles
- Glucocorticoid Receptors, Brain-Derived Neurotrophic Factor, Serotonin and Dopamine Neurotransmission are Associated with Interferon-Induced Depression Journal Articles
- Herpes Simplex Virus ICP0 Mutants Are Hypersensitive to Interferon Journal Articles
- High efficacy of combined therapy with pegylated interferon plus ribavirin in patients with hemophilia and chronic hepatitis C. Journal Articles
- IL-15 and IFN-γ signal through the ERK pathway to inhibit HCV replication, independent of type I IFN signaling Journal Articles
- Impact of Asian Race on Response to Combination Therapy With Peginterferon Alfa-2a and Ribavirin in Chronic Hepatitis C Journal Articles
- Infectious salmon anaemia virus replication and induction of alpha interferon in Atlantic salmon erythrocytes Journal Articles
- Inhibition of Warfarin Activity by Ribavirin Journal Articles
- Lessons learned from the Sunbelt Melanoma Trial Journal Articles
- Letter to the Editor Journal Articles
- Long Term Follow-Up of Patients with Chronic Hepatitis C Treated with Alpha Interferon Journal Articles
- Metastatic renal cell cancer treatments: An indirect comparison meta-analysis Journal Articles
- Multiomics analysis of rheumatoid arthritis yields sequence variants that have large effects on risk of the seropositive subset Journal Articles
- NK and NKT Cell-Independent Contribution of Interleukin-15 to Innate Protection against Mucosal Viral Infection Journal Articles
- Network meta-analysis of direct-acting antivirals in combination with peginterferon–ribavirin for previously untreated patients with hepatitis C genotype 1 infection Journal Articles
- Outcomes of Chronic Hepatitis C Therapy in Patients Treated in Community Versus Academic Centres in Canada: Final Results of APPROACH (A Prospective Study of Peginterferon alfa-2a and Ribavirin at Academic and Community Centres in Canada) Journal Articles
- PML has a predictive role in tumor cell permissiveness to interferon-sensitive oncolytic viruses Journal Articles
- Paranoid psychosis and cognitive impairment associated with hepatitis C antiviral therapy Journal Articles
- Peginterferon Plus Ribavirin for Chronic Hepatitis C in Patients With Human Immunodeficiency Virus Journal Articles
- Peginterferon alpha-2a is associated with higher sustained virological response than peginterferon alfa-2b in chronic hepatitis C: Systematic review of randomized trials Journal Articles
- Peginterferon alpha-2a versus peginterferon alpha-2b for chronic hepatitis C Journal Articles
- Peginterferon plus ribavirin versus interferon plus ribavirin for chronic hepatitis C Journal Articles
- Phase II Trial of 13-cis-Retinoic Acid Plus Interferon in Non-Small-Cell Lung Cancer: For the National Cancer Instit ute of Canada Clinical Trials Group Journal Articles
- Randomized trial of interferon maintenance in multiple myeloma: a study of the National Cancer Institute of Canada Clinical Trials Group. Journal Articles
- Real-world effectiveness of peginterferon α-2b plus ribavirin in a Canadian cohort of treatment-naïve chronic hepatitis C patients with genotypes 2 or 3: results of the PoWer and RediPEN studies Journal Articles
- Reinduction of remission of chronic myeloid leukemia by donor leukocyte transfusion following relapse after bone marrow transplantation: recovery complicated by initial pancytopenia and late dermatomyositis. Journal Articles
- Retreatment with Pegylated Interferon Alpha-2a and Ribavirin in Patients with Chronic Hepatitis C Who Have Relapsed or Not Responded to a First Course of Pegylated Interferon-Based Therapy Journal Articles
- Structural and functional studies of an IRF-7-like gene from Atlantic salmon Journal Articles
- Suppression of Immunological Response Against a Transgene Product Delivered from Microencapsulated Cells Journal Articles
- Taurocholic acid inhibits the response to interferon-α therapy in patients with HBeAg-positive chronic hepatitis B by impairing CD8+ T and NK cell function. Journal Articles
- Treatment effects on patient-important outcomes can be small, even with large effects on surrogate markers Journal Articles
- Treatment of the Chronic Phase of Chronic Myeloid Leukemia with an Intermittent Schedule of Recombinant Interferon Alfa-2b and Cytarabine: Results from CALGB Study 9013 Conferences
- Type I IFN blockade uncouples immunotherapy-induced antitumor immunity and autoimmune toxicity Journal Articles
- Type I IFN signaling on dendritic cells is required for NK cell-mediated anti-tumor immunity Journal Articles
- p53-paralog DNp73 oncogene is repressed by IFNα/STAT2 through the recruitment of the Ezh2 polycomb group transcriptional repressor Journal Articles